Start for free
Start for free
Medytox Venture Investment logo

Medytox Venture Investment

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Medytox Venture Investment is a TIPS operator that provides opportunities and supports growth in the healthcare sector.

Investor Profile

Medytox Venture Investment has made 5 investments, with 3 in the past 12 months and 20% as lead.

Stage Focus

  • Series A (40%)
  • Series B (40%)
  • Series C (20%)

Country Focus

  • South Korea (100%)

Industry Focus

  • Pharmaceutical
  • Biotechnology
  • Medical
  • Test And Measurement
  • Artificial Intelligence (Ai)
  • Product Research
  • Biopharma
  • Cannabis
  • Health Care
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Medytox Venture Investment frequently co-invest with?

SGI Venture Capital
SGI Venture Capital
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Bilanx Investment
Bilanx Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Quad Asset Management
Quad Asset Management
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Scale Up Partners
Scale Up Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Partners Investment
Partners Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Premier Partners
Premier Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
K2 Investment Partners
K2 Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
IBK Capital
IBK Capital
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Meritz Securities
Meritz Securities
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by Medytox Venture Investment?

Dime Bio

Seongnam, Kyonggi-do, South Korea

Dime Bio is a drug development company for novel dementia treatments.

MedicalPharmaceuticalTest and Measurement
Series AMar 26, 2025
Amount Raised: $8,183,930
Inventera Pharmaceuticals

Seocho, Seoul-t'ukpyolsi, South Korea

Inventera Pharmaceutical is a biotechnology company that specializes in the development of imaging diagnostic contrast agents.

BiotechnologyPharmaceutical
Series COct 30, 2024
Amount Raised: $13,428,092
AIGEN Sciences

Seoul, Seoul-t'ukpyolsi, South Korea

AIGEN Sciences is an AI drug discovery platform that provides drug research and development services.

Artificial Intelligence (AI)BiotechnologyPharmaceuticalProduct Research
Series AOct 16, 2024
Amount Raised: $8,794,744
NeoCannBio

Seoul, Seoul-t'ukpyolsi, South Korea

NeoCannBio offers natural product processing for natural goods and has created a hemp and medical cannabis cannabinoid library.

BiopharmaCannabisHealth Care
Series BSep 26, 2023
Amount Raised: $7,383,838
Ticaros

Seongdong, Kyonggi-do, South Korea

Ticaros is a biotech company that develops immune anti-cancer drugs.

BiotechnologyClinical TrialsPharmaceuticalTherapeutics
Series BJan 9, 2020
Amount Raised: $5,264,021
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator